ScholarIQanswers from OpenAlex
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
PaperCitations, authors & open-access status
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma have?
ScholarIQcitation count
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma has 532 citations in the OpenAlex counts ScholarIQ stores.
When was Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma published?
ScholarIQyear
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma has 2022 year in the ScholarIQ index.
What is the open-access status of Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma?
ScholarIQoa status
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma has green oa status in the ScholarIQ index.
What is the OpenAlex record for Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma?
ScholarIQopenalex
The OpenAlex for Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma is on the source record.